Home › Triple-Negative Breast Cancer › Illinois › Evanston
Triple-Negative Breast Cancer clinical trials in Evanston, IL
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Evanston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RecruitingPhase 3
- Orchard Healthcare Research Inc. ( Site 0014), Skokie · 2 mi away
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RecruitingPhase 3
- NorthShore University Healthsystem, Evanston
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
RecruitingPhase 1/2
- Kellogg Cancer Center, Evanston
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN27 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO20 studies
- Arlington, VA20 studies
- Atlanta, GA19 studies
- Dallas, TX18 studies
- Columbus, OH16 studies
- Chicago, IL16 studies
Other studies in Evanston
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer19 studies
- Breast Cancer13 studies
- Acute Myeloid Leukemia11 studies
- Obesity11 studies
- Cancer (all types)10 studies
- Crohn's Disease9 studies
- Ulcerative Colitis9 studies
- Overweight9 studies
- Prostate Cancer9 studies
- Colorectal Cancer9 studies
- Atrial Fibrillation8 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.